Why Mindray’s BeneHeart C2 AED aims to make public rescue less intimidating

Reviewed: ad hoc news Lifestyle & Consumer desk. Edited and checked on 2026-06-19, 07:48. Details in the imprint.

With the BeneHeart C2 AED from Mindray, the first impression is almost disarming - bright casing, large color screen, a big green shock button inviting action instead of fear. In a chaotic cardiac arrest, this compact box wants to guide untrained hands with calm, almost insistent clarity.

What the BeneHeart C2 promises

The BeneHeart C2 AED is Mindray’s semi-automated external defibrillator for public access locations, from airports to gyms and office corridors. It is designed for adult and pediatric patients and can be operated in fully automatic or semi-automatic modes.

Mindray highlights a so-called ResQNavi interactive interface that adjusts voice prompts and on-screen guidance to the detected user behavior, aiming to shorten hesitation before shock delivery. Clear diagrams on the display show pad placement, while a metronome supports chest compression rhythm.

Design, handling, everyday feel

On the table, the BeneHeart C2 looks tidy and approachable rather than clinical. Rounded edges, a carrying handle, and a hinged lid suggest “grab and go” rather than complex hospital device. The large shock button visually dominates the control surface.

In use, the workflow stays linear. Open the lid, the device powers up, and loud voice instructions take over, backed by animations on the color screen. For many users this combination of spoken guidance and simple visuals is more reassuring than a beeping box with cryptic lights.

Smart features and connectivity

The BeneHeart C2 can be equipped with Wi-Fi to transmit event data and self-test reports to a central management system, which is attractive for operators managing fleets across campuses or municipal buildings. Regular self-tests and remote status checks help keep devices ready without daily manual inspection.

Connectivity, however, comes with a trade-off. Mindray’s recent correction notice for the BeneHeart C series in Australia stresses that automatic sending of self-test reports via Wi-Fi or cellular can reduce battery life if left permanently active. Operators are advised to disable this function if not needed.

Battery, pads, and maintenance

Mindray specifies a non-rechargeable lithium battery for the BeneHeart C2 with a stand-by life of up to five years, depending on configuration and self-test frequency. A clear battery icon on the screen indicates remaining power; replacement is mandatory once the indicator shows low charge.

The AED uses pre-connected electrode pads sealed in a pouch, which reduces the number of steps in an emergency. Pediatric use is enabled either via a dedicated child mode or pediatric pads, depending on configuration, so buyers need to match accessories to their environment carefully.

Where users must pay attention

Mindray’s Australian notice on the BeneHeart C Series underlines that users should unplug used pads and connect new ones before turning off the AED after therapy. This step ensures the device recognizes fresh electrodes for the next rescue cycle.

For operators, that sounds trivial. In practice, however, it often gets lost in the adrenaline after an emergency. Training and clear internal procedures remain critical, even with a highly guided device like the BeneHeart C2.

Target group and positioning

Mindray positions the BeneHeart C2 squarely in the so-called public access defibrillation segment, alongside devices from Philips, ZOLL, and HeartSine. Its combination of color display, adaptive prompts, and remote management targets organizations that want more than a basic, text-only AED.

Compared with higher-end professional defibrillators, the C2 deliberately omits advanced ECG features and manual defib modes. That keeps the interface uncluttered for lay rescuers while hospitals and emergency services stick to their multi-parameter monitors.

Price level and availability

Official list prices for the BeneHeart C2 vary by configuration and region; specialized distributors in Europe and Asia typically list it in the mid-range AED segment rather than as a bargain entry. Consumables like pads and replacement batteries add recurring costs over the device’s lifespan.

In many European countries and in Australia, Mindray distributes the BeneHeart line through medical equipment dealers and its own regional subsidiaries. Buyers usually source the device as part of a package including wall cabinet, signage, and initial training.

Company context and stock

For Mindray, the BeneHeart C2 AED is one spoke in a large wheel of life-support and patient-monitoring products that span from intensive care units to ambulances. The company increasingly emphasizes connected device fleets and cloud-based maintenance to lock in institutional customers.

Shares of Shenzhen Mindray Bio-Medical (CNE100003G62) trade on the Shenzhen Stock Exchange, where the company is one of the larger medical-technology listings by market capitalization.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.